Clinical Trials
| Cancer Type: Breast | |
| Description: Phase III Trial of Continuous Schedule AC + G Vs. Q 2 Week Schedule AC, Followed by Paclitaxel Given Either Every 2 Weeks or Weekly for 12 Weeks as Post-Operative Adjuvant Therapy in Node-Positive or High- Risk Node Negative Breast Cancer |
|
| Entity Approving The Trial: Southwest Oncology Group (SWOG) |
|
| Phase: III | |
| Site-Wide Accrual Goal: 3,250 | |
| Related Files | |
| No related files found. | |
| Related Links | |
| http://www.cancer.gov/search/viewclinicaltrials.aspx?version=healthprofessional&cdrid=334899 |
 |
 |
|
